Property Name |
Property Value |
Unit |
Raw Value |
Raw Unit |
Annotation |
Reference |
AUC |
991.0 |
ng.h/ml |
991.0 |
ng.h/ml |
intravenous injection, IV; metastatic prostate cancer; |
DRUGBANK |
C Max |
226.0 |
ng/ml |
226 |
ng/ml |
intravenous injection, IV; metastatic prostate cancer; |
DRUGBANK |
T Max |
1.0 |
h |
1 |
h |
intravenous injection, IV; metastatic prostate cancer; |
DRUGBANK |
Metabolic |
95.0 |
% |
>95 |
% |
Liver metabolism; |
DRUGBANK |
Clearance |
48.5 |
L/h |
48.5 |
L/h |
Plasma clearance; metastatic prostate cancer; |
DRUGBANK |
Clearance |
0.66 |
L/h/kg |
11 |
ml/min/kg |
intravenous injection, IV; human, homo sapiens; |
Human Intravenous Pharmacokinetic Dataset |
Volume of Distribution |
4864.0 |
L |
4864.0 |
L |
at steady state; |
DRUGBANK |
Volume of Distribution |
48.0 |
L/kg |
48 |
L/kg |
intravenous injection, IV; human, homo sapiens; |
Human Intravenous Pharmacokinetic Dataset |
Half-life |
0.0667 |
h |
4 |
min |
distribution half-life; intravenous infusion, IV in drop; |
DRUGBANK |
Half-life |
2.0 |
h |
2 |
h |
elimination half-life; intravenous infusion, IV in drop; |
DRUGBANK |
Half-life |
95.0 |
h |
95 |
h |
terminal half-life; intravenous infusion, IV in drop; |
DRUGBANK |
Half-life |
74.5 |
h |
74.5 |
h |
intravenous injection, IV; human, homo sapiens; |
Human Intravenous Pharmacokinetic Dataset |
Toxicity LD50 |
500.0 |
mg/kg |
500.0 |
mg/kg |
Rattus, Rat; |
DRUGBANK |
Eliminate Route |
80.0 |
% |
~80 |
% |
intravenous infusion, IV in drop; |
DRUGBANK |
Protein Binding |
82.0 |
% |
82 |
% |
human, homo sapiens; |
DRUGBANK |